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In 1993, John Bergan and Mitchel Goldman present-
ed the first edition of their book. Now, 6 years later, they 
have added Robert Weiss, like Mitchel Goldman, a derma-
tologic surgeon, to edit the second edition. They have pro-
duced an update on the diagnosis and treatment of telang-
iectases and varicose veins, with a light touch on more 
severe venous disease. The interest for phlebology is on the 
rise in the United States. This has been a tradition in 
Scandinavia, in some of the northern European countries, 
including the United Kingdom, in some of the South 
American countries, and in Australia. The first "bible" in 
venous disease was Dodd and Cockett's The pathology and 
sut;gery of the veins from 1956. It was 10 years before the 
Swedish surgeon Knut Haeger published his Venous and 
lymphatic disorders of the leg in 1966, followed by George 
Fegan's Varicose veins in 1967, in which he described his 
theories on incompetent perforators and sclerotherapy. 
The Austrian surgeon and phlebologist Robert May pub-
lished his Chirut;gie der Bein und Beckenvenen in 1971, 
translated into English in 1979, and John Hobbs from St 
Mary's in London presented the international anthology 
The treatment of venous disorders in 1977 . John Bergan and 
Jimmy Yao, who got his venous inoculation at St Mary's in 
London in the 1960s, riposted with the three books from 
their popular Chicago symposia: Venous problems in 1978, 
Venous surgery in 1984, and Venous disorders in 1990. In 
1988, Sir Norman Browse and his coworkers from St 
Thomas' hospital in London presented the second "bible" 
in phlebology Diseases of the veins, which appeared in its 
updated second edition last year. In 1989, we published 
Controversies in the management of venous disorders to cel-
ebrate the 25th anniversary of Societas Phlebologica 
Scandinavica. The 1990s have seen many books in phle-
bology in Europe, South America, and the United States as 
an expression for the increasing interest in venous disease. 
This book contains 24 chapters, including 15 from 
North America, seven from Europe, and one each from 
Australia and South America. The chapters are distributed 
into five parts: fundamental considerations, diagnostic eval-
uation, treatment options, complex problems involving 
varicose veins, and telangiectatic leg veins. There are four 
new chapters that illustrate developments over the last 6 
years. Bergan writes about classification and surgical care of 
chronic venous insufficiency. He acknowledges Kistner 
who, in his presidential address, emphasized that if 
progress is to be made in the management of chronic 
venous disease, it is necessary to define the cause, location, 
and pathophysiology of the disease process in each case. 
These are the cornerstones of the CEAP classification, sub-
ject to Bergan's critical analysis. In his wisdom, he suggests 
that "the greatest contribution of the CEAP classification 
will be as a stimulus for a more sophisticated approach to 
the causes of venous valve and vein wall damage ... " In his 
chapter on surgical care, we can argue about the techniques 
and criteria used to determine valvular incompetence. He 
advocates van Bemmelen's cuff technique, which I think 
few clinicians use in daily practice. Bergan acknowledges 
the difficulties of assessing functional obstruction and 
underlines the importance of ascending and descending 
phlebography before deep venous reconstruction. The 
SEPS procedure for incompetent perforators is described, 
and the pioneering role of Kistner since his first valvulo-
plasty in 1966 for deep venous reconstruction is con-
firmed. Weiss and Goldman describe two new methods: 
treatment of incompetent saphenous vein with radiofre-
quency-mediated endovenous shrinkage and occlusion and 
obliteration of telangiectases using laser and high-intensity 
pulsed light. It seems slightly premature that they can rec-
ommend the endovenous techniques based on their limit-
ed experience. However, more than 200 patients in Europe 
have been treated with the Closure catheter, which now is 
FDA approved. They have an important discussion on dif-
ferent lasers and conclude that "optimal efficacy in treating 
common leg telangiectasies is achieved by using a combi-
nation of sclerotherapy followed by laser. .. " 
If repetition is the mother of learning, the editors have 
reached their goal to educate us. You can read the first 
four entertaining chapters on the existing theories on 
causes of varicose veins. In an editorial note, there is an 
attempt to unify the concept of developing varicose veins 
into simultaneous destruction of valves and production of 
vein wall weakness through the destruction by leucocyte 
infiltration. Or you can enjoy three chapters on scle-
rotherapy for varicose veins, representing views from Paris, 
Vancouver, and Dallas. This is a very extensive text on 
varicose veins, but, for the completeness, I miss informa-
tion about cuffing of incompetent saphenous valves and 
the controversial French-Italian CHIVA procedure. I rec-
ommend this book to all surgeons and phlebologists who 
deal with patients suffering from varicose veins and telan-
giectasies. The symbol of this book, In Unione Salus, fits 
well with the motto in the seal of the University of Lund, 
Ad Utrumque Paratus, to be prepared for both. The mod-
ern therapist has many weapons to choose from, but he or 
she must at least be prepared to use the knife as well as the 
syringe. Buy the book: as compared with the first edition, 
you will receive 114 pages extra for $36 less. 
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